These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27320894)

  • 1. [Characteristics of lymphocyte phenotypes in HBV transgenic mice and the effect of interferon-α: a preliminary study].
    Yan X; Zhong RH; Liu JH; Zhou Y; Tang LB; Li YY; Liu GZ; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):870-4. PubMed ID: 27320894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlational analysis of alternation of clinical features of intrahepatic lymphocyte subsets with HBV virology and liver fibrosis in HBV-Tg composite CCl(4) mice model].
    Sun X; Huang K; Zhang M; Liu HL; Zhao ZM; Tao YY; Peng Y; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):580-585. PubMed ID: 32791793
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of intrahepatic CD4+CXCR5+ T and CD19+ B cells is associated with viral clearance in a mouse model of acute hepatitis B virus infection.
    Song XF; Hu TT; Lei Y; Li H; Zhang L; Zhang M; Liu B; Chen M; Hu HD; Ren H; Hu P
    Oncotarget; 2016 Aug; 7(32):50952-50962. PubMed ID: 27447555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and immune function improvement of vitamin D combined with IFN-α on mouse with hepatitis B infection.
    Bi Y; Zhang W; Sun J; Gao R
    Int J Immunopathol Pharmacol; 2018; 32():2058738418775250. PubMed ID: 29745286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection.
    Song J; Zhou Y; Li S; Wang B; Zheng X; Wu J; Gibbert K; Dittmer U; Lu M; Yang D
    PLoS One; 2014; 9(3):e90977. PubMed ID: 24618716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
    Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
    Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
    Li D; Xu DZ; Choi BC; Men K; Zhang JX; Lei XY; Yan YP
    J Med Virol; 2005 Jun; 76(2):203-7. PubMed ID: 15834875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice].
    Tang Y; Chen X; Zhou L; Zhuo M; Zang G; Tang Z; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):24-9. PubMed ID: 24721239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γδ T cells are indispensable for interleukin-23-mediated protection against Concanavalin A-induced hepatitis in hepatitis B virus transgenic mice.
    Meng Z; Wang J; Yuan Y; Cao G; Fan S; Gao C; Wang L; Li Z; Wu X; Wu Z; Zhao L; Yin Z
    Immunology; 2017 May; 151(1):43-55. PubMed ID: 28092402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective detection of human hepatitis B virus surface and core antigens in some peripheral blood mononuclear cell subsets by flow cytometry.
    Chemin I; Vermot-Desroches C; Baginski I; Saurin JC; Laurent F; Zoulim F; Bernaud J; Lamelin JP; Hantz O; Rigal D
    J Clin Lab Immunol; 1992; 38(2):63-71. PubMed ID: 1343349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV.
    Wursthorn K; Buggisch P; Lutgehetmann M; Zollner B; Petersen J
    Antivir Ther; 2006; 11(5):647-52. PubMed ID: 16964835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
    Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Morrey JD; Korba BE; Sidwell RW
    Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BATF Interference Blocks Th17 Cell Differentiation and Inflammatory Response in Hepatitis B Virus Transgenic Mice.
    Chen LY; Fan XP; Fan YC; Zhao J; Gao S; Li F; Qi ZX; Wang K
    Dig Dis Sci; 2019 Mar; 64(3):773-780. PubMed ID: 30498928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.